Viewing nowRasagiline Tablets 0.5 mg (Rasagiline Mesylate)
Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Hyundai Pharmaceutical Co., Ltd.

MFDS item code 201907567 · Approved 2019.10.30
Treatment of idiopathic Parkinson's disease
For the treatment of idiopathic Parkinson's disease, it is initially managed with monotherapy or adjunctive treatments using dopamine agonists. Additionally, for patients exhibiting end of dose fluctuations, levodopa is administered as adjunctive therapy to enhance effectiveness. These medications help improve the motor symptoms of Parkinson's disease.
This medicine is administered orally to adults once daily, either as monotherapy or as adjunctive therapy. 1) Monotherapy or adjunctive therapy to a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy to levodopa: The recommended initial dose in patients taking levodopa is 0.5mg once daily. If well tolerated and the clinical response is insufficient, the dose may be increased to 1mg once daily. This medicine may be taken with or without food.
This medication should not be administered to patients with allergic reactions to the active ingredient or other components. Patients currently taking other MAO inhibitors or certain natural medicines, or those who have discontinued them within the last two weeks, should not take this medication. Patients taking medications such as pethidine, tramadol, or dextromethorphan should also avoid this medication. Patients with moderate to severe liver dysfunction may face risks while taking this medication, so it should not be administered. During treatment with this medication, symptoms such as headache, dizziness, nausea, insomnia, myalgia, hallucinations, and depression may occur; consult a physician if any unusual symptoms arise. This medication can lead to serious side effects such as hypertension, hypotension, impulse control disturbances, drowsiness, or sudden sleep attacks, so caution is advised. Particularly, when driving or operating machinery, extra care must be taken due to the risk of drowsiness or sleep attacks. This medication interacts with many other drugs, so inform healthcare providers of any other medications currently being taken. Women who are pregnant or breastfeeding should exercise caution when using this medication, and its safety has not been established for children. Overdose may lead to severe side effects, so it is crucial to adhere to the prescribed dosage and usage. This medication should be stored out of reach of children, and the storage temperature should be maintained between 1 and 25 degrees Celsius.
influenza
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a closed container. A cool place with a storage temperature between 1 and 25 degrees Celsius is suitable. Storing it this way helps maintain the medication's efficacy for a longer period.
White round tablets
30 tablets/box [(10 tablets/PTP*3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRasagiline Mesylate 0.78mg
Tablet · Prescription medication
Hyundai Pharmaceutical Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Hana Lundbeck Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Korea Lundbeck Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Korea Pharma Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.